These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17469311)

  • 1. [Towards evidence-based therapy in primary systemic vasculitis. Progress during the past decades have improved the situations of today's patients].
    Segelmark M; Westman K
    Lakartidningen; 2007 Mar 21-27; 104(12):954-7. PubMed ID: 17469311
    [No Abstract]   [Full Text] [Related]  

  • 2. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 3. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
    Holle JU; Gross WL
    J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based management of ANCA vasculitis.
    Carruthers D; Sherlock J
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 6. How to induce remission in primary systemic vasculitis.
    Jayne D
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):293-305. PubMed ID: 15857797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
    Jayne DR; Rasmussen N
    Mayo Clin Proc; 1997 Aug; 72(8):737-47. PubMed ID: 9276602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Progress of treatment in ANCA-associated vasculitis.
    Jayne D
    Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR recommendations for the management of primary small and medium vessel vasculitis.
    Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
    Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic vasculitis treatment and monitoring update, 2008.
    Yazici Y
    Bull NYU Hosp Jt Dis; 2008; 66(3):228-30. PubMed ID: 18937637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical practice guideline for ANCA-associated vasculitis with renal involvement].
    Vazquez V; Fayad A; González G; Smuclir Quevedo A; Robaina Sindín J;
    Medicina (B Aires); 2015; 75 Suppl 1():1-38. PubMed ID: 26738202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Gelber AC
    N Engl J Med; 2009 Mar; 360(13):1358-9; author reply 1359. PubMed ID: 19330939
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory vasculitis.
    Rutgers A; Kallenberg CG
    Autoimmun Rev; 2011 Sep; 10(11):702-6. PubMed ID: 21600312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vasculitis.
    Burns A
    Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):389-92. PubMed ID: 9509040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
    Kötter I
    Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
    [No Abstract]   [Full Text] [Related]  

  • 16. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic interventions in systemic sclerosis.
    van den Hoogen FH
    Neth J Med; 1998 Sep; 53(3):137-8. PubMed ID: 9803147
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological therapy of vasculitis: an update.
    Uthman I
    Curr Opin Pharmacol; 2004 Apr; 4(2):177-82. PubMed ID: 15063363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Historical perspective on the classification of vasculitis.
    Matteson EL
    Arthritis Care Res; 2000 Apr; 13(2):122-7. PubMed ID: 14635285
    [No Abstract]   [Full Text] [Related]  

  • 20. Current therapies for systemic vasculitis.
    Valente RM; Conn DL
    Semin Neurol; 1994 Dec; 14(4):380-6. PubMed ID: 7709088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.